With FDA Clearance, Molecular Matrix Looks to Make a Lasting Clinical Impact

When Molecular Matrix founder Charles Lee first began experimenting with stem cells as an undergraduate at UC Davis, the idea of running a biotechnology startup probably seemed far fetched. With the Food and Drug Administration’s clearance of Molecular Matrix’s synthetic bone graft product Osteo-P, however, Lee now finds himself using this startup to drive significant innovations in healthcare. Perhaps most exciting for the young entrepreneur is that, thanks to UC Davis, he’s been able to be a part of the project every step of the way.

It was his mentor Alice Tarantal, a professor of pediatrics at the the UC Davis School of Medicine, who first gave him a line of stem cells to culture. Lee fell in love with the possibilities offered by his research, namely the idea of creating a polymer platform for growing these stem cells into layers. While this had certainly been done before, Lee’s solution was unique in that it utilized cross-linked carbohydrate molecules to create a structure that not only allows for stem cell growth, but also degrades once that growth is accomplished in a way that does not affect the cells themselves.

He worked on this as he completed a PhD, as well as postdoctoral work, all at UC Davis. In 2011, UC Davis believed in the work so much that they helped him found Molecular Matrix. The company used this polymer structure that Lee had created and managed to develop a product, Osteo-P, that would help bones regrow, this time without stem cell transplantation.

This is particularly impactful for patients who have had bone removed in surgery and as the graft acts as a support and guide for the patient’s own bone growth. This means that, eventually the grafted Osteo-P will be completely replaced with new bone growth. For the university, their involvement in Molecular Matrix, and their inter-departmental commitment to its success, is a prime example of how it is able to make a lasting societal impact.

With the recent announcement that Osteo-P has cleared FDA regulations for clinical use, Lee is experiencing a dream realized. He has surrounded himself with a passionate and engaged team, receives help from the university to attract funding, and continues to offer students opportunities to work with Molecular Matrix both as interns and employees. Just as his professor had done when he started, Lee is helping to encourage a love for polymer development and stem cell research in the newest generation of student scientists.

Follow us on social media for the latest updates in B2B!


How the United Nation’s Global Compact Will Guide Volta’s ESG Stance
March 27, 2023

On today’s episode of the Volta Knowledge podcast, host Tyler Kern chats with Gursaran Singh, the VP of Energy Alliances with Volta Energy, about the upcoming UN global compact and how their decisions will impact and inform Volta’s ESG stance.  The global temperature is rising at an unprecedented rate. As such, discussions on the issue of climate change are held […]

Read More
business management
Investing for Success: Expert Advice on Business Management and Wealth Building
March 27, 2023

Starting a business from scratch can be a challenging but rewarding experience. To manage your business successfully, it’s essential to begin by developing a comprehensive business management plan. This plan should include your goals, target audience, products or services, marketing and sales strategies, and financial projections. It should serve as a roadmap for your […]

Read More
Teach For America
Teach For America Reinvention: Culture Transformation and Educator Recruitment
March 27, 2023

Teach For America (TFA) started with an idea in 1989 by Wendy Kopp. The TFA formally launched in 1990 with a mission to provide all children in America with an excellent education. More than thirty-three years later, TFA is continually improving itself by expanding its network and resources with initiatives like TFA’s Reinvention Lab. […]

Read More